ADADPresident Biden highlighted the urgent need to produce more of the specialty syringes — called low dead space syringes, because they are more efficient — in his pandemic response plan unveiled this week. “HHS did, however, notify the FDA of potential long-term shortages” of low dead space syringes. AD“Low dead space syringes are niche products, and there has been minimal market demand based on health-care provider needs,” BD spokesman Troy Kirkpatrick said. Of the 286 million, 40 million will be low dead space syringes, the company said. AD“It wasn’t planned that low dead space syringes were going to be needed for the vaccination efforts,” Kirkpatrick said.

Source: Washington Post January 23, 2021 01:51 UTC